Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.
Adventitia
Atherosclerosis
Fibroblasts
Heterogeneity
Single-cell RNA-seq
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
04 07 2023
04 07 2023
Historique:
received:
23
05
2022
revised:
21
10
2022
accepted:
04
11
2022
medline:
5
7
2023
pubmed:
1
2
2023
entrez:
31
1
2023
Statut:
ppublish
Résumé
Specific fibroblast markers and in-depth heterogeneity analysis are currently lacking, hindering functional studies in cardiovascular diseases (CVDs). Here, we established cell-type markers and heterogeneity in murine and human arteries and studied the adventitial fibroblast response to CVD and its risk factors hypercholesterolaemia and ageing. Murine aorta single-cell RNA-sequencing analysis of adventitial mesenchymal cells identified fibroblast-specific markers. Immunohistochemistry and flow cytometry validated platelet-derived growth factor receptor alpha (PDGFRA) and dipeptidase 1 (DPEP1) across human and murine aorta, carotid, and femoral arteries, whereas traditional markers such as the cluster of differentiation (CD)90 and vimentin also marked transgelin+ vascular smooth muscle cells. Next, pseudotime analysis showed multiple fibroblast clusters differentiating along trajectories. Three trajectories, marked by CD55 (Cd55+), Cxcl chemokine 14 (Cxcl14+), and lysyl oxidase (Lox+), were reproduced in an independent RNA-seq dataset. Gene ontology (GO) analysis showed divergent functional profiles of the three trajectories, related to vascular development, antigen presentation, and/or collagen fibril organization, respectively. Trajectory-specific genes included significantly more genes with known genome-wide associations (GWAS) to CVD than expected by chance, implying a role in CVD. Indeed, differential regulation of fibroblast clusters by CVD risk factors was shown in the adventitia of aged C57BL/6J mice, and mildly hypercholesterolaemic LDLR KO mice on chow by flow cytometry. The expansion of collagen-related CXCL14+ and LOX+ fibroblasts in aged and hypercholesterolaemic aortic adventitia, respectively, coincided with increased adventitial collagen. Immunohistochemistry, bulk, and single-cell transcriptomics of human carotid and aorta specimens emphasized translational value as CD55+, CXCL14+ and LOX+ fibroblasts were observed in healthy and atherosclerotic specimens. Also, trajectory-specific gene sets are differentially correlated with human atherosclerotic plaque traits. We provide two adventitial fibroblast-specific markers, PDGFRA and DPEP1, and demonstrate fibroblast heterogeneity in health and CVD in humans and mice. Biological relevance is evident from the regulation of fibroblast clusters by age and hypercholesterolaemia in vivo, associations with human atherosclerotic plaque traits, and enrichment of genes with a GWAS for CVD.
Identifiants
pubmed: 36718802
pii: 7016360
doi: 10.1093/cvr/cvad016
pmc: PMC10318398
doi:
Substances chimiques
Collagen
9007-34-5
Receptor Protein-Tyrosine Kinases
EC 2.7.10.1
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1509-1523Subventions
Organisme : British Heart Foundation
ID : RG/20/5/34796
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/14/3/30706
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N008340/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 219542/Z/19/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W015919/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 219542/Z/19/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/11/2/28733
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: None declared.
Références
Cardiovasc Res. 2022 May 6;118(6):1452-1465
pubmed: 33989378
Curr Opin Lipidol. 2020 Oct;31(5):273-278
pubmed: 32773464
J Clin Invest. 2004 May;113(9):1258-65
pubmed: 15124016
Circulation. 2016 Oct 11;134(15):1105-1121
pubmed: 27562971
Stem Cell Reports. 2017 Aug 8;9(2):681-696
pubmed: 28757161
Immune Netw. 2018 Feb 20;18(1):e11
pubmed: 29503741
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1408-1427
pubmed: 33626908
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Antioxid Redox Signal. 2017 Sep 1;27(7):379-397
pubmed: 28010122
Prog Nucleic Acid Res Mol Biol. 2001;70:1-32
pubmed: 11642359
Circulation. 2020 Nov 24;142(21):2045-2059
pubmed: 32674599
BMC Med. 2013 May 01;11:117
pubmed: 23635324
J Exp Med. 2009 Oct 26;206(11):2483-96
pubmed: 19841085
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Nat Med. 2019 Aug;25(8):1280-1289
pubmed: 31359001
Nat Commun. 2018 Nov 1;9(1):4567
pubmed: 30385745
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1722-1726
pubmed: 28663257
J Intern Med. 2014 Nov;276(5):525-36
pubmed: 24588843
Cell Rep. 2018 Mar 27;22(13):3625-3640
pubmed: 29590628
Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1598-1607
pubmed: 28705796
Cell Mol Life Sci. 2006 Oct;63(19-20):2304-16
pubmed: 16909208
Circulation. 2020 Nov 24;142(21):2060-2075
pubmed: 32962412
Circulation. 2020 Oct 6;142(14):1374-1388
pubmed: 33017217
Atherosclerosis. 2022 Jan;340:12-22
pubmed: 34871816
Circ Res. 2017 Mar 3;120(5):848-861
pubmed: 28003219
Nat Commun. 2020 May 5;11(1):2202
pubmed: 32371953
Cell Stem Cell. 2017 Feb 2;20(2):261-273.e3
pubmed: 27867035
Clin Transl Med. 2021 Jun;11(6):e458
pubmed: 34185408
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
Nat Biotechnol. 2019 Dec;37(12):1482-1492
pubmed: 31796933
Cardiovasc Res. 2019 Oct 1;115(12):1705-1715
pubmed: 31350876
Circulation. 1997 Jun 17;95(12):2684-93
pubmed: 9193438
Nat Commun. 2016 Jun 24;7:11853
pubmed: 27340017
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1262-75
pubmed: 10807742
Circulation. 2019 Jul 9;140(2):147-163
pubmed: 31146585
Mol Cell Biol. 2007 Feb;27(3):983-92
pubmed: 17130243
J Cell Biochem. 2019 Aug;120(8):13372-13381
pubmed: 30920024
Nat Commun. 2018 Jul 20;9(1):2865
pubmed: 30030434
Circ Res. 2021 Dec 3;129(12):1175-1177
pubmed: 34661425
Cell Stem Cell. 2015 Jan 8;16(1):51-66
pubmed: 25465115
Nat Commun. 2019 Feb 8;10(1):650
pubmed: 30737373
Nat Commun. 2020 Aug 7;11(1):3953
pubmed: 32769974
J Cardiovasc Transl Res. 2020 Apr;13(2):215-224
pubmed: 31728901
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
In Vivo. 2021 Nov-Dec;35(6):3137-3146
pubmed: 34697144
Am J Pathol. 2011 Oct;179(4):1601-7
pubmed: 21816131
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1055-1071
pubmed: 30943771
Cell Stem Cell. 2020 Jan 2;26(1):81-96.e4
pubmed: 31883835
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Cardiovasc Res. 2004 Mar 1;61(4):745-55
pubmed: 14985071
J Exp Med. 2017 Sep 4;214(9):2715-2732
pubmed: 28838952
Cells Tissues Organs. 2012;195(1-2):73-81
pubmed: 22005572
J Inflamm (Lond). 2016 Jan 05;13:1
pubmed: 26733763
Circulation. 2022 Mar 29;145(13):987-1001
pubmed: 35143327